A new drug that slows the pace of Alzheimer’s disease is too expensive for too little benefit to be used on the NHS, the watchdog says.
Source link : https://www.bbc.com/news/articles/c1e7pllez0xo
Author :
Publish date : 2024-10-23 09:02:04
Copyright for syndicated content belongs to the linked Source.